Advisor Group Holdings, Inc. Rigel Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.72 - $1.56 $1,440 - $3,120	2,000 Added 142.35%	3,405 $4,000
Q1 2022 May 04, 2022	SELL	$2.22 - $3.45 $222 - $345	-100 Reduced 6.64%	1,405 $4,000
Q3 2021 Nov 05, 2021	BUY	$3.5 - $4.5 $350 - $450	100 Added 7.12%	1,505 $5,000
Q4 2020 Feb 10, 2021	SELL	$2.35 - $3.74 $21,150 - $33,660	-9,000 Reduced 86.5%	1,405 $5,000
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $2,670 - $6,195	-1,500 Reduced 12.6%	10,405 $24,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $8,562 - $12,449	6,073 Added 104.13%	11,905 $22,000
Q1 2020 May 18, 2020	BUY	$1.27 - $3.0 $7,406 - $17,496	5,832 New	5,832 $9,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.94B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.